poisar

Stocks · News reference

Caribou Biosciences Reports Longer Follow Up Data For Ongoing CaMMouflage Phase 1 Trial Of CB-011, Off-The-Shelf BCMA-Targeted CAR-T Cell Therapy, Being Evaluated For r/r MM

Benzinga Newsdesk

-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months ---- Case study of a patient who

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CRBU
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks

    An analysis of stocks with strong potential to deliver earnings surprises identifies five companies: Allstate (ALL), Wayfair (W), BILL Holdings (BILL), Twilio (TWLO), and Caribou Biosciences (CRBU). These stocks were selected based on positive earnings surprise history, strong Zacks Rank ratings, positive Earnings ESP, and solid long-term growth prospects. Historical data shows these companies have consistently beaten market expectations, with Allstate averaging a 45.34% earnings surprise over the past four quarters.

    ALLALLPBALLPHALLPIALLPJ